Date
stringlengths
23
23
Article_title
stringlengths
0
512
Stock_symbol
stringlengths
0
6
Url
stringlengths
0
1.89k
Publisher
stringlengths
0
46
Author
stringlengths
0
253
Article
stringlengths
0
87.9k
Lsa_summary
stringclasses
1 value
Luhn_summary
stringclasses
1 value
Textrank_summary
stringclasses
1 value
Lexrank_summary
stringclasses
1 value
2020-06-05 06:30:54 UTC
Stocks That Hit 52-Week Highs On Friday
A
https://www.benzinga.com/news/20/06/16190091/stocks-that-hit-52-week-highs-on-friday
Benzinga Insights
2020-06-03 06:45:20 UTC
Stocks That Hit 52-Week Highs On Wednesday
A
https://www.benzinga.com/news/20/06/16170189/stocks-that-hit-52-week-highs-on-wednesday
Benzinga Insights
2020-05-26 00:30:07 UTC
71 Biggest Movers From Friday
A
https://www.benzinga.com/news/20/05/16103463/71-biggest-movers-from-friday
Lisa Levin
2020-05-22 08:45:06 UTC
46 Stocks Moving In Friday's Mid-Day Session
A
https://www.benzinga.com/news/20/05/16095921/46-stocks-moving-in-fridays-mid-day-session
Lisa Levin
2020-05-22 07:38:59 UTC
B of A Securities Maintains Neutral on Agilent Technologies, Raises Price Target to $88
A
https://www.benzinga.com/news/20/05/16095304/b-of-a-securities-maintains-neutral-on-agilent-technologies-raises-price-target-to-88
Vick Meyer
2020-05-22 07:23:25 UTC
CFRA Maintains Hold on Agilent Technologies, Lowers Price Target to $85
A
https://www.benzinga.com/news/20/05/16095163/cfra-maintains-hold-on-agilent-technologies-lowers-price-target-to-85
vishwanath@benzinga.com
2020-05-22 05:36:20 UTC
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87
A
https://www.benzinga.com/news/20/05/16094027/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-87
vishwanath@benzinga.com
2020-05-22 05:07:04 UTC
Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
A
https://www.benzinga.com/wiim/20/05/16093805/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q2-ep
Benzinga Newsdesk
2020-05-22 04:37:59 UTC
Wells Fargo Maintains Overweight on Agilent Technologies, Raises Price Target to $95
A
https://www.benzinga.com/news/20/05/16093505/wells-fargo-maintains-overweight-on-agilent-technologies-raises-price-target-to-95
vishwanath@benzinga.com
2020-05-22 04:06:17 UTC
10 Biggest Price Target Changes For Friday
A
https://www.benzinga.com/analyst-ratings/price-target/20/05/16093262/10-biggest-price-target-changes-for-friday
Lisa Levin
2020-05-22 00:00:00 UTC
30 Stocks Moving in Friday's Pre-Market Session
A
https://www.benzinga.com/news/20/05/16092879/30-stocks-moving-in-fridays-pre-market-session
Lisa Levin
2020-05-22 00:00:00 UTC
SVB Leerink Maintains Outperform on Agilent Technologies, Raises Price Target to $95
A
https://www.benzinga.com/news/20/05/16092270/svb-leerink-maintains-outperform-on-agilent-technologies-raises-price-target-to-95
vishwanath@benzinga.com
2020-05-21 00:00:00 UTC
8 Stocks Moving In Thursday's After-Hours Session
A
https://www.benzinga.com/news/20/05/16089803/8-stocks-moving-in-thursdays-after-hours-session
Tyree Gorges
2020-05-21 00:00:00 UTC
Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
A
https://www.benzinga.com/wiim/20/05/16089218/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q2-ep
Benzinga Newsdesk
2020-05-21 00:00:00 UTC
Agilent Technologies Q2 Adj. EPS $0.71 Beats $0.61 Estimate, Sales $1.24B Beat $1.21B Estimate
A
https://www.benzinga.com/news/earnings/20/05/16088886/agilent-technologies-q2-adj-eps-0-71-beats-0-61-estimate-sales-1-24b-beat-1-21b-estimate
Benzinga Newsdesk
2020-05-21 00:00:00 UTC
Earnings Scheduled For May 21, 2020
A
https://www.benzinga.com/news/earnings/20/05/16082427/earnings-scheduled-for-may-21-2020
Lisa Levin
2020-05-18 00:00:00 UTC
Agilent Technologies Receives FDA Approval for PD-L1 as a Companion Diagnostic
A
https://www.benzinga.com/news/20/05/16054223/agilent-technologies-receives-fda-approval-for-pd-l1-as-a-companion-diagnostic
Luke J Jacobi
2020-05-16 00:00:00 UTC
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
A
https://www.benzinga.com/news/20/05/16051311/q1-13f-roundup-how-buffett-einhorn-ackman-and-others-adjusted-their-portfolios
Wayne Duggan
2020-05-15 00:00:00 UTC
Pershing Square 13F Shows Fund Raises Stake In Agilent Technologies To 12,626,593 Shares
A
https://www.benzinga.com/general/hedge-funds/20/05/16048806/pershing-square-13f-shows-fund-raises-stake-in-agilent-technologies-to-12-626-593-shares
Benzinga Newsdesk
2020-05-08 00:00:00 UTC
How Bill Ackman Successfully Navigated Coronavirus Market Volatility
A
https://www.benzinga.com/general/education/20/05/15979110/how-bill-ackman-successfully-navigated-coronavirus-market-volatility
Wayne Duggan
2020-05-05 00:00:00 UTC
Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session.
A
https://www.benzinga.com/wiim/20/05/15957697/shares-of-several-healthcare-companies-are-trading-higher-amid-positive-investor-sentiment-as-some-u
Benzinga Newsdesk
2020-05-01 00:00:00 UTC
Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions.
A
https://www.benzinga.com/20/05/15935673/shares-of-several-healthcare-companies-are-trading-lower-as-markets-dip-following-recent-strength-ma
Benzinga Newsdesk
2020-04-28 00:00:00 UTC
UBS Maintains Neutral on Agilent Technologies, Lowers Price Target to $84
A
https://www.benzinga.com/news/20/04/15897306/ubs-maintains-neutral-on-agilent-technologies-lowers-price-target-to-84
vishwanath@benzinga.com
2020-04-23 00:00:00 UTC
Agilent Reports FDA Approval For PD-L1 Companion Diagnostic On Dako Omni
A
https://www.benzinga.com/news/20/04/15864339/agilent-reports-fda-approval-for-pd-l1-companion-diagnostic-on-dako-omni
Benzinga Newsdesk
2020-04-22 00:00:00 UTC
Agilent Reports Has Become Top-Level Sponsor Of My Green Lab
A
https://www.benzinga.com/news/20/04/15855436/agilent-reports-has-become-top-level-sponsor-of-my-green-lab
Benzinga Newsdesk
2020-04-14 00:00:00 UTC
Agilent Withdraws Q2 And FY20 Guidance
A
https://www.benzinga.com/news/20/04/15796369/agilent-withdraws-q2-and-fy20-guidance
Benzinga Newsdesk
2020-04-08 00:00:00 UTC
Shares of several companies in the auto dealer space are trading higher amid positive market sentiment. Speculation some coronavirus hotspots leveling off has raised hopes of a return to economic activity, which could mean a rebound in consumer spending.
A
https://www.benzinga.com/wiim/20/04/15769071/shares-of-several-companies-in-the-auto-dealer-space-are-trading-higher-amid-positive-market-sentime
Benzinga Newsdesk
2020-04-06 00:00:00 UTC
Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.
A
https://www.benzinga.com/wiim/20/04/15748126/shares-of-several-healthcare-companies-are-trading-higher-as-markets-gain-amid-optimism-that-coronav
Benzinga Newsdesk
2020-04-02 00:00:00 UTC
Stifel Maintains Hold on Agilent Technologies, Lowers Price Target to $73
A
https://www.benzinga.com/news/20/04/15728603/stifel-maintains-hold-on-agilent-technologies-lowers-price-target-to-73
Vick Meyer
2020-04-01 00:00:00 UTC
Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.
A
https://www.benzinga.com/wiim/20/04/15717065/shares-of-several-healthcare-companies-are-trading-lower-amid-market-weakness-as-growing-coronavirus
Benzinga Newsdesk
2020-03-31 00:00:00 UTC
Int'l. Air Transport Authority Chief Economist Sees Consolidation In Airline Sector As Some Airlines Fail, Calls Signs In Chinese Domestic Market 'Encouraging,' Load Factors Are About 60%
A
https://www.benzinga.com/news/20/03/15705690/intl-air-transport-authority-chief-economist-sees-consolidation-in-airline-sector-as-some-airlines-f
Benzinga Newsdesk
2020-03-30 00:00:00 UTC
Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $82
A
https://www.benzinga.com/news/20/03/15695415/wells-fargo-maintains-overweight-on-agilent-technologies-lowers-price-target-to-82
Vick Meyer
2020-03-30 00:00:00 UTC
Shares of several technology companies are trading higher as equities continue to rise following last week's rebound amid US stimulus measures.
A
https://www.benzinga.com/wiim/20/03/15695372/shares-of-several-technology-companies-are-trading-higher-as-equities-continue-to-rise-following-las
Benzinga Newsdesk
2020-03-27 00:00:00 UTC
Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.
A
https://www.benzinga.com/wiim/20/03/15683827/shares-of-several-healthcare-companies-are-trading-lower-selling-off-from-this-weeks-strength-while
Benzinga Newsdesk
2020-03-26 00:00:00 UTC
Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.
A
https://www.benzinga.com/wiim/20/03/15674560/shares-of-several-healthcare-companies-are-trading-higher-following-senate-passage-of-a-2-trillion-e
Benzinga Newsdesk
2020-03-26 00:00:00 UTC
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76
A
https://www.benzinga.com/news/20/03/15673665/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76
Vick Meyer
2020-03-26 00:00:00 UTC
Ariel Chairman John Rogers Thinks Current Market Is 'Once In A Lifetime Opportunity To Buy Stocks'
A
https://www.benzinga.com/news/20/03/15668620/ariel-chairman-john-rogers-thinks-current-market-is-once-in-a-lifetime-opportunity-to-buy-stocks
Shivdeep Dhaliwal
2020-03-20 00:00:00 UTC
Citigroup Maintains Neutral on Agilent Technologies, Lowers Price Target to $75
A
https://www.benzinga.com/news/20/03/15615851/citigroup-maintains-neutral-on-agilent-technologies-lowers-price-target-to-75
Vick Meyer
2020-03-16 00:00:00 UTC
Stocks That Hit 52-Week Lows On Monday
A
https://www.benzinga.com/news/20/03/15560273/stocks-that-hit-52-week-lows-on-monday
Benzinga Newsdesk
2020-03-16 00:00:00 UTC
Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.
A
https://www.benzinga.com/wiim/20/03/15558425/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-on-cont
Benzinga Newsdesk
2020-03-13 00:00:00 UTC
Shares of several basic materials companies are trading higher, rebounding following Thursday's crash. The sector has been volatile amid the coronavirus outbreak, which has disrupted economic activity. NOTE: While markets rebound, virus fears persist.
A
https://www.benzinga.com/wiim/20/03/15546085/shares-of-several-basic-materials-companies-are-trading-higher-rebounding-following-thursdays-crash
Benzinga Newsdesk
2020-03-12 00:00:00 UTC
Stocks That Hit 52-Week Lows On Thursday
A
https://www.benzinga.com/news/20/03/15538835/stocks-that-hit-52-week-lows-on-thursday
Lisa Levin
2020-03-11 00:00:00 UTC
Shares of several coronavirus-related companies including vaccine makers, protective apparel manufacturers and emergency medical suppliers are trading higher as the coronavirus continues to spread globally.
A
https://www.benzinga.com/wiim/20/03/15528213/shares-of-several-coronavirus-related-companies-including-vaccine-makers-protective-apparel-manufact
luke@benzinga.com
2020-03-03 00:00:00 UTC
Agilent Technologies Inc Says In January 2020, Net Revenue Was Negatively Impacted Due To The Public Health Crisis In China; Says In Jan 2020, Net Revenue Negatively Impacted Also Due To Extension Of Lunar New Year Resulting In Fewer Selling Days In Month
A
https://www.benzinga.com/news/20/03/15472189/agilent-technologies-inc-says-in-january-2020-net-revenue-was-negatively-impacted-due-to-the-public
luke@benzinga.com
2020-03-02 00:00:00 UTC
Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears.
A
https://www.benzinga.com/wiim/20/03/15456786/shares-of-several-healthcare-companies-are-trading-higher-in-sympathy-with-the-overall-market-as-it
Benzinga Newsdesk
2020-02-24 00:00:00 UTC
Benzinga's Top Upgrades, Downgrades For February 24, 2020
A
https://www.benzinga.com/analyst-ratings/upgrades/20/02/15393664/benzingas-top-upgrades-downgrades-for-february-24-2020
Lisa Levin
2020-02-24 00:00:00 UTC
Shares of several software companies are trading lower as the coronavirus cases surge outside of China. NOTE: The virus has raised fear of a global economic slowdown.
A
https://www.benzinga.com/wiim/20/02/15392140/shares-of-several-software-companies-are-trading-lower-as-the-coronavirus-cases-surge-outside-of-chi
Benzinga Newsdesk
2020-02-24 00:00:00 UTC
Needham Downgrades Agilent Technologies to Hold, Announces $85 Price Target
A
https://www.benzinga.com/news/20/02/15391251/needham-downgrades-agilent-technologies-to-hold-announces-85-price-target
Vick Meyer
2020-02-19 00:00:00 UTC
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $90
A
https://www.benzinga.com/news/20/02/15363071/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-90
Vick Meyer
2020-02-18 00:00:00 UTC
12 Stocks Moving In Tuesday's After-Hours Session
A
https://www.benzinga.com/news/20/02/15359453/12-stocks-moving-in-tuesdays-after-hours-session
Tyree Gorges
2020-02-18 00:00:00 UTC
Agilent Technologies shares are trading lower after the company reported Q1 earnings.
A
https://www.benzinga.com/wiim/20/02/15358745/agilent-technologies-shares-are-trading-lower-after-the-company-reported-q1-earnings
Benzinga Newsdesk
2020-02-18 00:00:00 UTC
Agilent Reaffirms FY20 Guidance: Adj. EPS $3.38-$3.43 vs $3.42 Estimate, Sales $5.5B-$5.55B vs $5.54B Est.
A
https://www.benzinga.com/news/20/02/15358631/agilent-reaffirms-fy20-guidance-adj-eps-3-38-3-43-vs-3-42-estimate-sales-5-5b-5-55b-vs-5-54b-est
Benzinga Newsdesk
2020-02-18 00:00:00 UTC
Agilent Technologies Q1 EPS $0.81, Inline, Sales $1.36B Up From $1.284B YoY
A
https://www.benzinga.com/news/earnings/20/02/15358612/agilent-technologies-q1-eps-0-81-inline-sales-1-36b-up-from-1-284b-yoy
Benzinga Newsdesk
2020-02-18 00:00:00 UTC
Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
A
https://www.benzinga.com/general/hedge-funds/20/02/15356890/q4-13f-roundup-how-buffett-einhorn-ackman-and-others-adjusted-their-portfolios
Wayne Duggan
2020-02-18 00:00:00 UTC
9 Stocks To Watch For February 18, 2020
A
https://www.benzinga.com/news/earnings/20/02/15351319/9-stocks-to-watch-for-february-18-2020
Lisa Levin
2020-02-18 00:00:00 UTC
Earnings Scheduled For February 18, 2020
A
https://www.benzinga.com/news/earnings/20/02/15351289/earnings-scheduled-for-february-18-2020
Lisa Levin
2020-02-14 00:00:00 UTC
Pershing Square 13F Shows Raised Stake In Agilent By 11.4% To 3.25M Shares
A
https://www.benzinga.com/general/hedge-funds/20/02/15343262/pershing-square-13f-shows-raised-stake-in-agilent-by-11-4-to-3-25m-shares
Benzinga Newsdesk
2020-02-06 00:00:00 UTC
Twist Bioscience Reports Settlement Deal With Agilent; Co. Will Pay Agilent $22.5M
A
https://www.benzinga.com/news/20/02/15274626/twist-bioscience-reports-settlement-deal-with-agilent-co-will-pay-agilent-22-5m
Benzinga Newsdesk
2020-02-06 00:00:00 UTC
Cowen Says Views Potential Twist-Agilent Settlement As 'a likely clearing event for additional investment in TWST'
A
https://www.benzinga.com/analyst-ratings/analyst-color/20/02/15272527/cowen-says-views-twist-agilent-settlement-as-a-likely-clearing-event-for-additional
Benzinga Newsdesk
2020-02-05 00:00:00 UTC
Pershing Square Sees 'Substantial Opportunity' For Improvement In Agilent's A.N Business Performance
A
https://www.benzinga.com/general/hedge-funds/20/02/15261019/pershing-square-sees-substantial-opportunity-for-improvement-in-agilents-a-n-business-perform
Benzinga Newsdesk
2020-01-30 00:00:00 UTC
Agilent shares are trading lower. Not seeing any news to justify the price action.
A
https://www.benzinga.com/wiim/20/01/15218404/agilent-shares-are-trading-lower-not-seeing-any-news-to-justify-the-price-action
Benzinga Newsdesk
2020-01-22 00:00:00 UTC
Stocks That Hit 52-Week Highs On Wednesday
A
https://www.benzinga.com/news/20/01/15163983/stocks-that-hit-52-week-highs-on-wednesday
Lisa Levin
2020-01-17 00:00:00 UTC
Stocks That Hit 52-Week Highs On Friday
A
https://www.benzinga.com/news/20/01/15144632/stocks-that-hit-52-week-highs-on-friday
Lisa Levin
2020-01-16 00:00:00 UTC
Stocks That Hit 52-Week Highs On Thursday
A
https://www.benzinga.com/news/20/01/15135505/stocks-that-hit-52-week-highs-on-thursday
Lisa Levin
2020-01-15 00:00:00 UTC
Stocks That Hit 52-Week Highs On Wednesday
A
https://www.benzinga.com/news/20/01/15129364/stocks-that-hit-52-week-highs-on-wednesday
Lisa Levin
2020-01-10 00:00:00 UTC
Stocks That Hit 52-Week Highs On Friday
A
https://www.benzinga.com/news/20/01/15106362/stocks-that-hit-52-week-highs-on-friday
Lisa Levin
2020-01-09 00:00:00 UTC
Stocks That Hit 52-Week Highs On Thursday
A
https://www.benzinga.com/news/20/01/15101221/stocks-that-hit-52-week-highs-on-thursday
Lisa Levin
2020-01-08 00:00:00 UTC
Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $100 Price Target
A
https://www.benzinga.com/news/20/01/15090063/wells-fargo-initiates-coverage-on-agilent-technologies-with-overweight-rating-announces-100-price-ta
Benzinga_Newsdesk
2020-01-07 00:00:00 UTC
Citigroup Initiates Coverage On Agilent Technologies with Neutral Rating, Announces $85 Price Target
A
https://www.benzinga.com/news/20/01/15082753/citigroup-initiates-coverage-on-agilent-technologies-with-neutral-rating-announces-85-price-target
Benzinga_Newsdesk
2020-01-03 00:00:00 UTC
Benzinga's Top Upgrades, Downgrades For January 3, 2020
A
https://www.benzinga.com/analyst-ratings/upgrades/20/01/15067917/benzingas-top-upgrades-downgrades-for-january-3-2020
Lisa Levin
2019-12-27 00:00:00 UTC
Stocks That Hit 52-Week Highs On Friday
A
https://www.benzinga.com/news/19/12/15047352/stocks-that-hit-52-week-highs-on-friday
Lisa Levin
2019-12-23 00:00:00 UTC
Stocks That Hit 52-Week Highs On Monday
A
https://www.benzinga.com/news/19/12/15033664/stocks-that-hit-52-week-highs-on-monday
Lisa Levin
2019-12-20 00:00:00 UTC
Stocks That Hit 52-Week Highs On Friday
A
https://www.benzinga.com/news/19/12/15026655/stocks-that-hit-52-week-highs-on-friday
Lisa Levin
2019-12-12 00:00:00 UTC
Stocks That Hit 52-Week Highs On Thursday
A
https://www.benzinga.com/news/19/12/14980573/stocks-that-hit-52-week-highs-on-thursday
Lisa Levin
2019-12-11 00:00:00 UTC
There's A New Trading Tool That Allows Traders To Trade Cannabis With Leverage
A
https://www.benzinga.com/markets/cannabis/19/12/14971438/theres-a-new-trading-tool-that-allows-traders-to-trade-cannabis-with-leverage
Spencer Israel
2019-12-10 00:00:00 UTC
Stocks That Hit 52-Week Highs On Tuesday
A
https://www.benzinga.com/news/19/12/14966014/stocks-that-hit-52-week-highs-on-tuesday
Lisa Levin
2019-12-10 00:00:00 UTC
PreMarket Prep Recap: Yo-Yo Market And After-Hours Overshoot On Ackman's New Stake
A
https://www.benzinga.com/trading-ideas/long-ideas/19/12/14965258/premarket-prep-recap-yo-yo-market-and-after-hours-overshoot-on-ackmans-new-stake
Joel Elconin
2019-12-10 00:00:00 UTC
41 Healthcare Stocks Moving In Tuesday's Pre-Market Session
A
https://www.benzinga.com/news/19/12/14961880/41-healthcare-stocks-moving-in-tuesdays-pre-market-session
Lisa Levin
2019-12-09 00:00:00 UTC
UPDATE: Bill Ackman's Pershing Square Files Amended 13F Showing New ~2.916M Share Stake In Agilent
A
https://www.benzinga.com/news/19/12/14957797/update-bill-ackmans-pershing-square-files-amended-13f-showing-new-2-916m-share-stake-in-agilent
Benzinga Newsdesk
2019-12-09 00:00:00 UTC
Hearing Pershing Square Reports 2.9M Share Stake In Agilent
A
https://www.benzinga.com/general/hedge-funds/19/12/14957729/hearing-pershing-square-reports-2-9m-share-stake-in-agilent
Benzinga Newsdesk
2019-12-06 00:00:00 UTC
Stocks That Hit 52-Week Highs On Friday
A
https://www.benzinga.com/news/19/12/14946306/stocks-that-hit-52-week-highs-on-friday
Lisa Levin
2019-11-26 00:00:00 UTC
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87
A
https://www.benzinga.com/news/19/11/14883967/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-87
Vick Meyer
2019-11-25 00:00:00 UTC
Aligent shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.
A
https://www.benzinga.com/wiim/19/11/14880060/aligent-shares-are-trading-higher-after-the-company-reported-better-than-expected-q4-eps-and-sales-r
Benzinga Newsdesk
2019-11-25 00:00:00 UTC
Agilent Sees FY20 Adj. EPS $3.38-$3.43 vs $3.44 Estimate, Sales $5.5B-$5.55B vs $5.55B Est.
A
https://www.benzinga.com/news/19/11/14880011/agilent-sees-fy20-adj-eps-3-38-3-43-vs-3-44-estimate-sales-5-5b-5-55b-vs-5-55b-est
Benzinga Newsdesk
2019-11-25 00:00:00 UTC
Agilent Sees Q1 Adj. EPS $0.80-$0.81 vs $0.84 Estimate, Sales $1.34B-$1.355B vs $1.38B Est.
A
https://www.benzinga.com/news/19/11/14880008/agilent-sees-q1-adj-eps-0-80-0-81-vs-0-84-estimate-sales-1-34b-1-355b-vs-1-38b-est
Benzinga Newsdesk
2019-11-25 00:00:00 UTC
Agilent Technologies Q4 Adj. EPS $0.89 Beats $0.85 Estimate, Sales $1.37B Beat $1.33B Estimate
A
https://www.benzinga.com/news/earnings/19/11/14880002/agilent-technologies-q4-adj-eps-0-89-beats-0-85-estimate-sales-1-37b-beat-1-33b-estimate
Benzinga Newsdesk
2019-11-25 00:00:00 UTC
7 Stocks To Watch For November 25, 2019
A
https://www.benzinga.com/news/earnings/19/11/14873358/6-stocks-to-watch-for-november-25-2019
Lisa Levin
2019-11-25 00:00:00 UTC
Earnings Scheduled For November 25, 2019
A
https://www.benzinga.com/news/earnings/19/11/14873325/earnings-scheduled-for-november-25-2019
Lisa Levin
2019-11-20 00:00:00 UTC
Agilent Raises Qtr. Dividend From $0.164 To $0.18/Share
A
https://www.benzinga.com/news/19/11/14852619/agilent-raises-qtr-dividend-from-0-164-to-0-18share
Benzinga Newsdesk
2019-11-15 00:00:00 UTC
Benzinga's Top Upgrades, Downgrades For November 15, 2019
A
https://www.benzinga.com/analyst-ratings/upgrades/19/11/14820877/benzingas-top-upgrades-downgrades-for-november-15-2019
Lisa Levin
2019-11-15 00:00:00 UTC
Stifel Nicolaus Initiates Coverage On Agilent Technologies with Hold Rating, Announces $85 Price Target
A
https://www.benzinga.com/news/19/11/14818776/stifel-nicolaus-initiates-coverage-on-agilent-technologies-with-hold-rating-announces-85-price-targe
Vick Meyer
2019-10-18 00:00:00 UTC
Benzinga's Top Upgrades, Downgrades For October 18, 2019
A
https://www.benzinga.com/analyst-ratings/upgrades/19/10/14619795/benzingas-top-upgrades-downgrades-for-october-18-2019
Lisa Levin
2019-10-18 00:00:00 UTC
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Fed Speakers
A
https://www.benzinga.com/news/earnings/19/10/14618733/a-peek-into-the-markets-us-stock-futures-edge-higher-ahead-of-fed-speakers
Lisa Levin
2019-10-18 00:00:00 UTC
UBS Downgrades Agilent Technologies to Neutral, Announces $82 Price Target
A
https://www.benzinga.com/news/19/10/14618513/ubs-downgrades-agilent-technologies-to-neutral-announces-82-price-target
Vick Meyer
2019-10-11 00:00:00 UTC
Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.
A
https://www.benzinga.com/markets/wiim/19/10/14582266/shares-of-several-healthcare-companies-are-trading-higher-after-president-trump-made-positive-remark
Benzinga Newsdesk
2019-10-09 00:00:00 UTC
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76
A
https://www.benzinga.com/news/19/10/14566662/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76
Vick Meyer
2019-10-08 00:00:00 UTC
Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.
A
https://www.benzinga.com/markets/wiim/19/10/14561148/shares-of-several-healthcare-companies-are-trading-lower-with-the-broader-market-after-the-us-expand
Benzinga Newsdesk
2019-10-02 00:00:00 UTC
Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.
A
https://www.benzinga.com/markets/wiim/19/10/14530664/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-on-cont
Benzinga Newsdesk
2019-09-05 00:00:00 UTC
Shares of several healthcare companies are trading higher in sympathy with the overall market after the Chinese Minister of Commerce said the leaders of the U.S. and China are set to meet in Washington D.C in early October. Investors hope the meeting could bring the two countries closer to a trade deal.
A
https://www.benzinga.com/markets/wiim/19/09/14385950/shares-of-several-healthcare-companies-are-trading-higher-in-sympathy-with-the-overall-market-after
Benzinga Newsdesk
2019-09-03 00:00:00 UTC
Agilent Collaborates On Study Of Performance-Enhancing Spinach Extract
A
https://www.benzinga.com/general/19/09/14364782/agilent-collaborates-on-study-of-performance-enhancing-spinach-extract
Benzinga Newsdesk
README.md exists but content is empty. Use the Edit dataset card button to edit it.
Downloads last month
0
Edit dataset card